Alnylam Pharmaceuticals, Inc.

{
  "main_header": {
    "sid": 1150089,
    "name": "Alnylam Pharmaceuticals, Inc.",
    "stock_name": "Alnylam Pharmaceuticals, Inc.",
    "full_name": "Alnylam Pharmaceuticals, Inc.",
    "name_url": "stocks-analysis/alnylam-pharmaceuticals-inc",
    "exchange": 1,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "357.98",
    "chg": 53.98,
    "chgp": "17.76%",
    "dir": 1,
    "prev_price": "304.00",
    "mcapval": "48,282.32",
    "mcap": "Large Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2305,
    "indexname": "S&P 500",
    "isin": "US02043Q1076",
    "curr_date": "Jan 23",
    "curr_time": "",
    "bse_nse_vol": "868.22 k",
    "exc_status": "Active",
    "traded_date": "Jan 23, 2026",
    "traded_date_str": "2026 01 23",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/alnylam-pharmaceuticals-inc-1150089-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is Alnylam Pharmaceuticals, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-alnylam-pharmaceuticals-inc-technically-bullish-or-bearish-3673628",
        "imagepath": "",
        "date": "2025-11-05 11:21:18",
        "description": "As of 31 October 2025, the technical trend for Alnylam Pharmaceuticals, Inc. has changed from bullish to mildly bullish. The weekly MACD and KST indicators are mildly bearish, while the monthly MACD and KST are bullish. The Bollinger Bands show a mildly bullish stance on both weekly and monthly time frames, and daily moving averages are also mildly bullish. However, Dow Theory indicates a mildly bearish trend on both weekly and monthly bases. \n\nIn terms of performance, Alnylam has significantly outperformed the S&P 500 year-to-date with a return of 79.96% compared to 16.30%, and over the past three years, it has returned 96.31% versus the S&P 500's 76.66%. Overall, the current technical stance is mildly bullish, supported by the monthly indicators and daily moving averages, despite some bearish signals in the weekly timeframe...."
      },
      {
        "title": "Is Alnylam Pharmaceuticals, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-alnylam-pharmaceuticals-inc-technically-bullish-or-bearish-3670808",
        "imagepath": "",
        "date": "2025-11-04 11:32:43",
        "description": "As of 31 October 2025, the technical trend for Alnylam Pharmaceuticals, Inc. has changed from bullish to mildly bullish. The current stance is mildly bullish, supported by daily moving averages and Bollinger Bands indicating mild bullishness. However, the weekly MACD and KST are mildly bearish, which tempers the overall outlook. The stock has performed well over the long term, with a year-to-date return of 84.47% compared to the S&P 500's 16.30%, and a 5-year return of 236.36% versus the S&P 500's 109.18%...."
      },
      {
        "title": "Is Alnylam Pharmaceuticals, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-alnylam-pharmaceuticals-inc-technically-bullish-or-bearish-3666410",
        "imagepath": "",
        "date": "2025-11-03 11:32:23",
        "description": "As of 31 October 2025, the technical trend for Alnylam Pharmaceuticals, Inc. has changed from bullish to mildly bullish. The weekly MACD and KST indicators are both mildly bearish, while the monthly MACD, KST, and Bollinger Bands are bullish. The daily moving averages indicate a mildly bullish stance. The On-Balance Volume is bullish for both weekly and monthly periods. \n\nIn terms of performance, Alnylam has significantly outperformed the S&P 500 year-to-date with a return of 93.80% compared to the S&P 500's 16.30%, and over the past year, it has returned 71.06% versus the S&P 500's 19.89%. Overall, the current technical stance is mildly bullish, driven by strong monthly indicators and positive long-term returns...."
      },
      {
        "title": "Is Alnylam Pharmaceuticals, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-alnylam-pharmaceuticals-inc-technically-bullish-or-bearish-3664524",
        "imagepath": "",
        "date": "2025-11-02 11:17:29",
        "description": "As of 31 October 2025, the technical trend for Alnylam Pharmaceuticals, Inc. has changed from bullish to mildly bullish. The weekly MACD and KST indicators are both mildly bearish, while the monthly MACD and KST are bullish. The Bollinger Bands show a mildly bullish stance on the weekly chart and bullish on the monthly chart. Daily moving averages indicate a mildly bullish trend. Overall, the current technical stance is mildly bullish, driven primarily by the monthly indicators and daily moving averages.\n\nIn terms of performance, Alnylam has significantly outperformed the S&P 500 year-to-date with a return of 93.80% compared to the S&P 500's 16.30%, and over the past year, it has returned 71.06% against the S&P 500's 19.89%...."
      },
      {
        "title": "Alnylam Pharmaceuticals Hits Day Low of $436.51 Amid Price Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alnylam-pharmaceuticals-hits-day-low-of-43651-amid-price-pressure-3662121",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/AlnylamPharmace_priceRelatedfactors_3662121.png",
        "date": "2025-10-31 16:59:25",
        "description": "Alnylam Pharmaceuticals experienced a notable decline in stock value on October 30, 2025, amid a challenging trading session. Despite recent fluctuations, the company has shown strong long-term performance, with significant gains over the past year and five years, although it faces challenges such as a net profit loss and low return on capital employed."
      },
      {
        "title": "Alnylam Pharmaceuticals Faces Weak Start with 6.56% Gap Down Amid Market Concerns",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alnylam-pharmaceuticals-faces-weak-start-with-656-gap-down-amid-market-concerns-3712433",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/AlnylamPharmace_gapdown_3712433.png",
        "date": "2025-10-31 16:42:18",
        "description": "Alnylam Pharmaceuticals, Inc. experienced a notable decline in stock performance, contrasting with the stable S&P 500. The company, valued at approximately USD 59.645 billion, faces challenges with negative return on equity and high price-to-book ratio. Technical indicators show mixed signals, reflecting a complex market environment."
      }
    ],
    "total": 12,
    "sid": "1150089",
    "stock_news_url": "https://www.marketsmojo.com/news/alnylam-pharmaceuticals-inc-1150089"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Is Alnylam Pharmaceuticals, Inc. technically bullish or bearish?

2025-11-05 11:21:18

As of 31 October 2025, the technical trend for Alnylam Pharmaceuticals, Inc. has changed from bullish to mildly bullish. The weekly MACD and KST indicators are mildly bearish, while the monthly MACD and KST are bullish. The Bollinger Bands show a mildly bullish stance on both weekly and monthly time frames, and daily moving averages are also mildly bullish. However, Dow Theory indicates a mildly bearish trend on both weekly and monthly bases. In terms of performance, Alnylam has significantly outperformed the S&P 500 year-to-date with a return of 79.96% compared to 16.30%, and over the past three years, it has returned 96.31% versus the S&P 500's 76.66%. Overall, the current technical stance is mildly bullish, supported by the monthly indicators and daily moving averages, despite some bearish signals in the weekly timeframe....

Read full news article

Is Alnylam Pharmaceuticals, Inc. technically bullish or bearish?

2025-11-04 11:32:43

As of 31 October 2025, the technical trend for Alnylam Pharmaceuticals, Inc. has changed from bullish to mildly bullish. The current stance is mildly bullish, supported by daily moving averages and Bollinger Bands indicating mild bullishness. However, the weekly MACD and KST are mildly bearish, which tempers the overall outlook. The stock has performed well over the long term, with a year-to-date return of 84.47% compared to the S&P 500's 16.30%, and a 5-year return of 236.36% versus the S&P 500's 109.18%....

Read full news article

Is Alnylam Pharmaceuticals, Inc. technically bullish or bearish?

2025-11-03 11:32:23

As of 31 October 2025, the technical trend for Alnylam Pharmaceuticals, Inc. has changed from bullish to mildly bullish. The weekly MACD and KST indicators are both mildly bearish, while the monthly MACD, KST, and Bollinger Bands are bullish. The daily moving averages indicate a mildly bullish stance. The On-Balance Volume is bullish for both weekly and monthly periods. In terms of performance, Alnylam has significantly outperformed the S&P 500 year-to-date with a return of 93.80% compared to the S&P 500's 16.30%, and over the past year, it has returned 71.06% versus the S&P 500's 19.89%. Overall, the current technical stance is mildly bullish, driven by strong monthly indicators and positive long-term returns....

Read full news article

Is Alnylam Pharmaceuticals, Inc. technically bullish or bearish?

2025-11-02 11:17:29

As of 31 October 2025, the technical trend for Alnylam Pharmaceuticals, Inc. has changed from bullish to mildly bullish. The weekly MACD and KST indicators are both mildly bearish, while the monthly MACD and KST are bullish. The Bollinger Bands show a mildly bullish stance on the weekly chart and bullish on the monthly chart. Daily moving averages indicate a mildly bullish trend. Overall, the current technical stance is mildly bullish, driven primarily by the monthly indicators and daily moving averages. In terms of performance, Alnylam has significantly outperformed the S&P 500 year-to-date with a return of 93.80% compared to the S&P 500's 16.30%, and over the past year, it has returned 71.06% against the S&P 500's 19.89%....

Read full news article

Alnylam Pharmaceuticals Hits Day Low of $436.51 Amid Price Pressure

2025-10-31 16:59:25

Alnylam Pharmaceuticals experienced a notable decline in stock value on October 30, 2025, amid a challenging trading session. Despite recent fluctuations, the company has shown strong long-term performance, with significant gains over the past year and five years, although it faces challenges such as a net profit loss and low return on capital employed.

Read full news article

Alnylam Pharmaceuticals Faces Weak Start with 6.56% Gap Down Amid Market Concerns

2025-10-31 16:42:18

Alnylam Pharmaceuticals, Inc. experienced a notable decline in stock performance, contrasting with the stable S&P 500. The company, valued at approximately USD 59.645 billion, faces challenges with negative return on equity and high price-to-book ratio. Technical indicators show mixed signals, reflecting a complex market environment.

Read full news article

View All News